StockData

Exozymes Inc. (EXOZ) stock

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.43+0.12 (+3.63%)

Close on Nov 18, 2026Market cap $31.84MP/E –Yield –

Exozymes shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Exozymes's shares outstanding was 9M at Sep 30, 2026. For fiscal 2025 it was 8M, up 27.7% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20258M+27.7%
FY2024Dec 31, 20247M+5.0%
FY2023Dec 31, 20236M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 20269M+10.8%
Q2 FY2026Jun 30, 20269M+3.4%
Q1 FY2026Mar 31, 20268M+1.1%
Q4 FY2025Dec 31, 20258M+11.9%
Q3 FY2025Sep 30, 20258M+34.1%
Q2 FY2025Jun 30, 20258M+34.0%
Q1 FY2025Mar 31, 20258M+33.9%
Q4 FY2024Dec 31, 20247M+20.0%
Q3 FY2024Sep 30, 20246M+0.0%
Q2 FY2024Jun 30, 20246M–
Q1 FY2024Mar 31, 20246M–
Q4 FY2023Dec 31, 20236M–
Q3 FY2023Sep 30, 20236M–

More Exozymes figures

See a number that looks wrong?